Abstract:Silk fibroin (SF) is a biomacromolecule that can be assembled into nanostructures and induce biomimetic nucleation of inorganic materials. Zeolitic imidazolate framework-8 (ZIF-8), a metal–organic framework (MOF), can be dissolved selectively under acidic pH. Here, we integrated SF and ZIF-8 to develop novel drug carriers that selectively release drug in the acidic intracellular environment of cancer cells. Specifically, SF was assembled into nanoparticles (SF-NPs), which were then loaded with an antitumor drug, doxorubicin (DOX), to form DSF-NPs. Due to the SF-mediated organization of ZIF-8 precursors such as zinc ions, the DSF-NPs further templated the nucleation of ZIF-8 onto their surface to generate core–shell-structured NPs (termed ) with ZIF-8 as a shell and DSF-NP as a core. We found that the , highly stable under neutral conditions, could be uptaken by breast cancer cells, release DOX selectively owing to dissolution of ZIF-8 shells in the acidic intracellular environment in a controlled manner, and induce cell apoptosis. We also confirmed that the could inhibit tumor growth more efficiently to reach a higher survival rate than their controls by inducing cell apoptosis in vivo. Our study suggests that SF and MOF could be combined to design a new type of cancer therapeutics.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.1c13405.Materials characterization, intracellular location, and biocompatibility; elemental line mapping of ; FTIR spectra of ZIF-8, , and SF-NPs; size distribution of DSF-NPs and ; loading capacity and EE of DOX onto SF-NPs with various concentrations; relative viability of MCF-7 cells cocultured with NPs; fluorescent images of the MCF-7 cells cocultured with FITC-labeled NPs; TEM images of (50 μg/mL) cocultured with MCF-7 cells for 12 h; H&E staining of normal organs (heart, spleen, lung, liver, and kidney) excised from the mice bearing MCF-7 tumors and treated with different NPs and their controls; polydispersity index of DSF-NPs and ; and chemical element analysis of (PDF)This article has not yet been cited by other publications.

Metal−Organic Frameworks Nucleated by Silk Fibroin and Modified with Tumor‐Targeting Peptides for Targeted Multimodal Cancer Therapy

Metal–Organic Frameworks-Based Nanoplatform for Treatment of Breast Cancer

F3‐functionalized Nanoscale Metal–organic Frameworks for Tumor‐targeting Combined Chemotherapy and Chemodynamic Therapy

Biomimetic Nucleation of Metal–Organic Frameworks on Silk Fibroin Nanoparticles for Designing Core–Shell-Structured pH-Responsive Anticancer Drug Carriers

Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors

Metal–Organic Framework/Graphene Quantum Dot Nanoparticles Used for Synergistic Chemo- and Photothermal Therapy

Metal organic framework-coated gold nanorod as an on-demand drug delivery platform for chemo-photothermal cancer therapy

Zn-Co metal organic frameworks coated with chitosand and Au nanoparticles for chemo-photothermal-targeted combination therapy of liver cancer

Erythrocyte Membrane Camouflaged Metal–Organic Framework Nanodrugs for Remodeled Tumor Microenvironment and Enhanced Tumor Chemotherapy

Biocompatible and biodegradable zeolitic imidazolate framework/polydopamine nanocarriers for dual stimulus triggered tumor thermo-chemotherapy

Acid-Responsive Decomposable Nanomedicine Based on Zeolitic Imidazolate Frameworks for Near-Infrared Fluorescence Imaging/Chemotherapy Combined Tumor Theranostics

Hyaluronic Acid Modified Halloysite Nanotubes Decorated with ZIF-8 Nanoparticles As Dual Chemo- and Photothermal Anticancer Agents

Cancer Cell-Targeted Photosensitizer and Therapeutic Protein Co-Delivery Nanoplatform Based on a Metal-Organic Framework for Enhanced Synergistic Photodynamic and Protein Therapy

A Dual Factor Activated Metal-Organic Framework Hybrid Nanoplatform for Photoacoustic Imaging and Synergetic Photo-Chemotherapy.

Rational Design of Metal Organic Framework Nanocarrier-Based Codelivery System of Doxorubicin Hydrochloride/Verapamil Hydrochloride for Overcoming Multidrug Resistance with Efficient Targeted Cancer Therapy.

Synthesis of dual-stimuli responsive metal organic framework-coated iridium oxide nanocomposite functionalized with tumor targeting albumin-folate for synergistic photodynamic/photothermal cancer therapy

Fe3O4‐Incorporated Metal‐Organic Framework for Chemo/Ferroptosis Synergistic Anti‐Tumor via the Enhanced Chemodynamic Therapy

PEGylated Nanoscale Metal-Organic Frameworks for Targeted Cancer Imaging and Drug Delivery.

Tailored Core‒shell Dual Metal–organic Frameworks As a Versatile Nanomotor for Effective Synergistic Antitumor Therapy

Biodegradable Core-shell Dual-Metal-Organic-Frameworks Nanotheranostic Agent for Multiple Imaging Guided Combination Cancer Therapy.

Coupling metal organic frameworks with molybdenum disulfide nanoflakes for targeted cancer theranostics